Literature DB >> 28442234

Impact of restrictive lung disorder on cardiovascular mortality in a general population: The Yamagata (Takahata) study.

Yuki Honda1, Tetsu Watanabe2, Yoko Shibata3, Yoichiro Otaki3, Shinpei Kadowaki3, Taro Narumi3, Tetsuya Takahashi3, Daisuke Kinoshita3, Miyuki Yokoyama3, Satoshi Nishiyama3, Hiroki Takahashi3, Takanori Arimoto3, Tetsuro Shishido3, Sumito Inoue3, Takuya Miyamoto3, Tsuneo Konta3, Ryo Kawasaki4, Makoto Daimon5, Takeo Kato4, Yoshiyuki Ueno4, Takamasa Kayama4, Isao Kubota1.   

Abstract

BACKGROUND: Obstructive lung disorder (OLD) is known to be associated with cardiovascular disease. However, the impact of restrictive lung disorder (RLD) on cardiovascular mortality has not been fully investigated in the apparently healthy general population.
OBJECTIVES: To clarify whether RLD is associated with cardiovascular mortality in the general population. METHODS AND
RESULTS: This community-based cohort study included 3247 subjects who participated in an annual health check in Takahata. We performed spirometry in registered subjects and found that 194 (6%) had RLD, 262 (8%) had OLD, and 73 (2%) had RLD and OLD (Mixed). During a 10-year follow-up, there were 210 deaths, including 57 cardiovascular deaths. Cardiovascular mortality of subjects with RLD was significantly higher than that of subjects with normal lung function. Although the subjects with RLD were younger, comprised fewer smokers, and were more likely to be female than those with OLD, cardiovascular mortality of subjects with RLD was comparable to that of subjects with OLD. Subjects with RLD had a higher prevalence of atrial fibrillation (AF) than those with OLD, and the prevalence of AF was increased with advanced severity of RLD. Multivariate Cox proportional hazard analysis revealed that RLD was an independent predictor of cardiovascular death (hazard ratio 2.61, 95% confidence interval, 1.22-5.21) after adjustment for confounders, but OLD was not. The net reclassification improvement and integrated discrimination improvement were significantly increased by the addition of RLD to conventional cardiovascular risk factors.
CONCLUSION: The presence of RLD was associated with cardiovascular mortality in the general population.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular mortality; General population; Obstructive lung disorder; Restrictive lung disorder

Mesh:

Year:  2017        PMID: 28442234     DOI: 10.1016/j.ijcard.2017.04.049

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.

Authors:  Emily S Wan; John E Hokanson; Elizabeth A Regan; Kendra A Young; Barry J Make; Dawn L DeMeo; Stefanie E Mason; Raul San Jose Estepar; James D Crapo; Edwin K Silverman
Journal:  Chest       Date:  2021-09-27       Impact factor: 9.410

2.  Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.

Authors:  Emily S Wan; Spyridon Fortis; Elizabeth A Regan; John Hokanson; MeiLan K Han; Richard Casaburi; Barry J Make; James D Crapo; Dawn L DeMeo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 30.528

3.  Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

Authors:  Hideyuki Mukai; Pei Ming; Bengt Lindholm; Olof Heimbürger; Peter Barany; Björn Anderstam; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  PLoS One       Date:  2018-04-27       Impact factor: 3.240

4.  Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study.

Authors:  Gang Wang; Jenny Hallberg; Dimitrios Charalampopoulos; Maribel Casas Sanahuja; Robab Breyer-Kohansal; Arnulf Langhammer; Raquel Granell; Judith M Vonk; Annemiek Mian; Núria Olvera; Lisbeth Mølgaard Laustsen; Eva Rönmark; Alicia Abellan; Alvar Agusti; Syed Hasan Arshad; Anna Bergström; H Marike Boezen; Marie-Kathrin Breyer; Otto Burghuber; Anneli Clea Bolund; Adnan Custovic; Graham Devereux; Gavin C Donaldson; Liesbeth Duijts; Ana Esplugues; Rosa Faner; Ferran Ballester; Judith Garcia-Aymerich; Ulrike Gehring; Sadia Haider; Sylvia Hartl; Helena Backman; John W Holloway; Gerard H Koppelman; Aitana Lertxundi; Turid Lingaas Holmen; Lesley Lowe; Sara M Mensink-Bout; Clare S Murray; Graham Roberts; Linnea Hedman; Vivi Schlünssen; Torben Sigsgaard; Angela Simpson; Jordi Sunyer; Maties Torrent; Stephen Turner; Maarten Van den Berge; Roel C H Vermeulen; Sigrid Anna Aalberg Vikjord; Jadwiga A Wedzicha; Anke H Maitland van der Zee; Erik Melén
Journal:  ERJ Open Res       Date:  2021-12-06

5.  Relationship between lung function impairment, hypertension, and major adverse cardiovascular events: A 10-year follow-up study.

Authors:  Jiaqi Wang; He Dai; Chong Chen; Ganling Ding; Yongqing Zhang; Yu Qin; Yuqing Zhang; Quanyong Xiang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-09-16       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.